临床试验/NCT03997084

NCT03997084已完成不适用

Patent Foramen Ovale Closure Reduce in SCUBA-divers

Skane University Hospital0 个研究点目标入组 9 人开始时间: 2017年1月1日最近更新: 2019年6月25日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Skane University Hospital
入组人数: 9
主要终点: Dives

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

It has been proposed that there would not be an increased risk of DCI after closure of the interatrial communication, i.e. patent foramen ovale (PFO).

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Retrospective

入排标准

性别: All
接受健康志愿者: 否

入选标准

•catheter-based PFO-closure because of DCI

排除标准

未提供

结局指标

主要结局

Dives

时间窗: 2017-01-01 until 2019-01-01

Interview based on a questionnaire with questions focusing on the dive habits and DCI events.

次要结局

未报告次要终点

研究者

发起方

Skane University Hospital

申办方类型

Other

责任方

Principal Investigator

主要研究者

Joanna Hlebowicz

MD, Associated Professor

Skane University Hospital

相似试验

已完成

不适用

Occlusive Skin Closure May Reduce Wound Drainage After Tumor Hip ArthroplastyMetastatic Bone Disease of the Proximal Femur

NCT03746717Rigshospitalet, Denmark70

终止

不适用

The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCIPFOStrokeTIAPatent Foramen Ovale

NCT01018355Hillerod Hospital, Denmark3,000

已完成

不适用

Chest closure without drainage after open patent ductus arteriosus ligation in Ugandan children. Open label randomized controlled trial.Patent ductus arteriosus

PACTR201207000395469MEPI CVD linked project86

进行中（未招募）

1 期

Comparison of three different strategies of preventing a second stroke in patients with a small hole in the wall dividing the right side of the heart from the left side:-two different forms of blood thinning medication: - long-time antiplatelet therapy - long-time anticoagulant therapyor - closure of the hole by implanting a small metal device using a catheter, followed by long-time antiplatelet therapyThe study compares different strategies for secondary stroke (or retinal ischaemia) prevention in patients with patent foramen ovale.The three treatment arms comprise: 1. Endovascular patent foramen ovale closure followed by long-term antiplatelet therapy 2. long-term anticoagulant therapy 3. long-term antiplatelet therapyMedDRA version: 19.0Level: LLTClassification code 10036654Term: PreventionSystem Organ Class: 100000004865MedDRA version: 19.0Level: LLTClassification code 10016982Term: Foramen ovale patentSystem Organ Class: 100000004850MedDRA version: 19.0Level: LLTClassification code 10042244Term: StrokeSystem Organ Class: 100000004852

EUCTR2011-000110-19-DEAssistance Publique – Hôpitaux de Paris (AP-HP)900

终止

不适用

InSeal Vascular Closure Device Clinical Study ProtocolPercutaneous Closure of Artery Access Sites

NCT01896401InSeal Medical Ltd.33